Search
for
Sort by
Research 211–240 of 312
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta‐analysis
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- COVID‐19, androgens, and androgenic alopecia
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats
- O potencial terapêutico da hidroxicloroquina no tratamento de alopecias autoimunes
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Clinical Efficacy of Platelet-Rich Plasma in the Management of Androgenetic Alopecia: A Prospective Comparative Study
- Therapeutic Updates on Lichen planopilaris and Frontal Fibrosing Alopecia: A Systematic Review
- Treatment of Frontal Fibrosing Alopecia in Black Patients: A Systematic Review
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
- Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair
- Finasteride Induced Clinical Ocular Toxicity
- Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study
- Association between finasteride with subjective memory deficits: a study from the NHANES and FAERS databases
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Efficacy of <i>Serenoa repens</i> lipido-sterolic extract alone or in combination with propolis polyphenols and <i>Boswellia serrata</i> extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial